"You have to come for an ultrasound every alternate day." This sounded overwhelming at first, but it was an essential part of my pregnancy journey. If you are trying to conceive and planning to opt ...
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced an ...
This two-arm prospective phase III open-label trial randomly assigns (1:1) participants with low–tumor burden FL who wish to pursue active management to rituximab versus mosunetuzumab (Fig 1), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results